Chicago has a long way to go when it comes to diabetes awareness amongst the general public, says pharmaceutical company Abbott. And if the picture in Chicago is representative of the nation as a whole, we should all be very concerned. Or should we? Yes, diabetes awareness - or lack thereof - is a problem. But is Abbott painting an overly pessimistic picture of the situation?

Abbott's comments about Chicago came as it announced the results of a poll sponsored to evaluate public understanding of diabetes in the city. The initiative was in preparation for the American Diabetes Association's Scientific Sessions, which begin June 22 in Chicago. (Abbott's North American home base is in Abbott Park, Illinois, near Chicago.)

Abbott's conclusion? Most people surveyed flunked out big-time when it came to basic facts like how diabetes affects the body and how the condition can be managed. The findings are as follows: twenty-eight percent of Chicagoans know little or nothing about diabetes, while thirty-five percent of non-diabetics say they are not prepared to manage diabetes should they themselves be diagnosed in the future. My view: the former is a problem, but at least it means a majority do know something about it. And what of the the latter (preparedness)? So what if many Average Joes say they're unprepared to deal with diabetes themselves. I'd bet very few people indeed would be prepared to manage a chronic condition with which they have not yet been diagnosed! Other findings portrayed by Abbott as problematic: twenty-three percent believe glucose monitoring involves pain, while eighteen percent believe diabetics cannot eat carbohydrates at all. Again, is the glass half empty or is it half full? Quite honestly, I'm pleasantly surprised that most of those polled know better. On the up-side, Abbott does acknowledge the good news that eighty-eight percent believe having diabetes does not necessarily preclude living a long and healthy life. Another factor to keep in mind: only five hundred people participated in the poll.

Bottom line: Abbott's press release paints an extremely, and I would say overly, dire picture of the situation. Yes, many people are still pretty darn ignorant about diabetes. They may not be able to write you an essay describing its exact cause or all the treatment options. However, most now grasp that it is a serious chronic condition. Is it hopelessly optimistic to believe that things can only get better from here?

In the next 3 to 5 years, we will have a new generation of control upon us providing continuous glucose monitoring. Some of these marvelous technologies will not require a drop of blood, while others will embody the tried-and-true stick-to-itiveness we all know and loathe.

Please join me as we browse the isles of things to come (and things now available) for continuous glucose monitoring.

The DexCom STS Continuous Glucose Monitoring System is a glucose sensor that reports glucose values every 5 minutes for up to 72 hours. The sensor is inserted in the abdomen. After a 2 hour start-up period, the STS System is calibrated with 2 fingerstick measurements taken by a traditional glucose meter. Checkout Amy Tenderich's review on Diabetes Mine of the DexCom Continuous Glucose Monitoring Sytem.

MiniMed Medtronic has 3 different versions: the Gold, the Guardian RT, and the Paradigm Real-Time Continuous Monitor.

Menarini GlucoDay S is a device worn by the patient for the continuous monitoring of glucose in the subcutaneous interstitial fluid. Monitoring is performed via insertion in the abdominal region of a microfibre for dialysis having the diameter of a human hair. Inside the microfibre a solution transports the patient's glucose to a biosensor within the instrument.

M-Biotech Glucose Biosensor is a minimally invasive implantation for painless and convenient monitoring. The key feature of our efficient Glucose Biosensor is the combination of a glucose-sensitive hydrogel and a miniature pressure sensor. Glucose-responsive hydrogels are biocompatible materials that either swell or contract when the glucose concentrations change in the body fluid surrounding the hydrogel.

The PreciSense System includes a microcapsule placement unit and a light detecting non-invasive reader unit. The microcapsule placement unit poses the right dose of glucose-responding microcapsules in the upper layer of the skin, painlessly. The glucose assay components in the microcapsules generate a fluorescence signal that corresponds to the glucose level. The non-invasive reader unit monitors this glucose binding event through FRET, Fluorescence Resonance Energy Transfer, which is directly related to the concentration of glucose.

Sensors for Medicine and Science glucose sensor is implanted under the skin in a short outpatient procedure. The sensor automatically measures interstitial glucose every few minutes, without any user intervention. The sensor implant will communicate wirelessly with a small external reader.

Synthetic Blood Implanted Glucose Biosensor claims to offer significantly more accurate glucose readings in a range of 30-500 mg/dl. The implanted Glucose Biosensor continuously monitors blood glucose without the need for finger sticks. The most accurate glucose monitor available, the implanted biosensor can be programmed to monitor blood glucose according to a predetermined schedule, thus eliminating problems of patient compliance. The sensor alarms for dangerous, life threatening conditions such as hypoglycemia.

GlucoLight Corporation is developing a low-cost non-invasive blood glucose monitor for home use by diabetic patents. GlucoLight's unique optical approach, microScatterTM (microscatter) technology, is based on patented technologies in the area of Optical Coherence Tomography (OCT) and Low Coherence Interferometry (LCI). There is a working prototype with published clinical data on healthy volunteers.

The GlucoWatch G2 Biographer was approved to detect glucose level trends and track patterns in people with diabetes. It must be used along with conventional blood glucose monitoring of blood samples. The device, which looks like a wristwatch, pulls body fluid from the skin using small electric currents. It can provide six measurements per hour for 13 hours. (See David Mendosa's review).

DexCom has developed a continuous glucose monitoring ("CGM") system that could be the next generation of aggressive control. The DexCom GCM is a device that measures glucose trends throughout the day, providing up to 288 glucose measurements every 24 hours.

A traditional glucose monitoring test -like finger sticks - leave gaps in time where you are uncertain as to your blood sugar reading. Continuous monitoring is different from traditional blood glucose monitoring because it affords a comprehensive picture of where your blood sugars are throughout the day and night. The trend reveals times throughout the day where your sugar may increase or decrease, as well as how fast it is happening. This trend information together with the glucose value shows you patterns and problems that traditional finger sticks cannot cover as thoroughly. CGM allows you to set a target range for your desired glucose. When your glucose goes above or below this range, an alert automatically lets you know.

A 2006 study showed that people who used this device were able to achieve a 23% decrease in time spent high and a 21% decrease in time spent low. After speaking with Dianne on the DexCom customer support line - she advised me that they are offering a $375 startup kit that has everything you need to get going. The Rechargeable STS Receiver has a sleek rounded design that can easily be carried with the carry case on both your belt or in a handbag. The STS Transmitter is lightweight and fits comfortably underneath clothing. The STS Sensor & Applicator is easy to insert and safe to use with no visible needles or exposed sharps. With this wireless system, no cables or wires will get in your way allowing you to Take Control and Live Uninterrupted.. Each sensor lasts for 3 days. A set of 5 sensors costs $175 and will last you approximately 15 days.

The annual cost of continuous glucose monitoring averages a ballpark figure of $4,258. Okay, sounds a little steep - but lean on Uncle Sam to offset the cost of the best control. Sounds like it might be time to open up a Flexible Spending Account and write-off the yearning for glucose precision.

One in five Americans online feel that the Internet has greatly improved the way they get their information about health care. Now there is a site for those who want to become more proactive in managing the disease. It's easier than ever to get the latest news and comprehensive information about the factors that play a key role in proper diabetes management. Looking for tips on healthier eating and diabetic recipes? Check. How about diabetic fitness and exercise? It's in there! Need some guidance on coping skills? You bet. Want to fine tune your understanding of diabetic care and blood sugar monitoring? Grab a chair and make yourself comfortable. There's plenty for everybody. Furthermore, there are perks like coupons and free goodies. The site is particularly relevant today, due to the fact two-thirds of type 2 diabetics have blood sugar averages that are out of control. Ouch.

OneTouchGold.com offers a comprehensive lineup of features. Registration is free and takes just a few minutes. That is the only requisite for free reign of the site. The OneTouch® Gold program provides members with an online magazine of the latest diabetes information covering a range of categories including food, fitness, coping, complications, medicines, and blood glucose monitoring. In addition, the site offers health-related coupons, product samples, and a monthly sweepstakes. The site also features monthly articles written by researchers at the Johns Hopkins School of Medicine and other experts in the field. In addition, members can elect to receive a monthly e-newsletter highlighting the latest diabetes news and health tips.

The OneTouch® Gold program is made possible by LifeScan, Inc. Kudos to the master minds behind OneTouchGold.com. They've opened a virtual schoolhouse for those in search of a diabetic higher learning.